NEW YORK (GenomeWeb News) – SQI Diagnostics reported after the close of the market on Tuesday that it had no revenues for its fiscal third quarter, compared to C$9,000 (US$9,064) from the year-ago period.

In documents filed with SEDAR, the Canadian financial information filing system, Toronto-based SQI said that the revenue drop resulted from one customer, Gamma Dynacare Medical Labs, choosing not to purchase QuantiSpot RA test kits in the quarter. Subsequent to the end of the third quarter, GDML reordered the kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.